These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22386653)

  • 1. PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression.
    Matsui T; Nishino Y; Maeda S; Yamagishi S
    Microvasc Res; 2012 Jul; 84(1):105-8. PubMed ID: 22386653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of chemical cautery-induced corneal neovascularization by topical pigment epithelium-derived factor eyedrops.
    Jin J; Ma JX; Guan M; Yao K
    Cornea; 2010 Sep; 29(9):1055-61. PubMed ID: 20539216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile INTeraction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis.
    Kuo CN; Yang LC; Yang CT; Lai CH; Chen MF; Chen CY; Chen CH; Wu PC; Kou HK; Chen YJ; Hung CH; Tsai CB
    Exp Eye Res; 2009 Nov; 89(5):678-85. PubMed ID: 19596319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties.
    Seki R; Yamagishi S; Matsui T; Yoshida T; Torimura T; Ueno T; Sata M; Okamura T
    Biochem Biophys Res Commun; 2013 Feb; 431(4):693-7. PubMed ID: 23375814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
    Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigment epithelium-derived factor (PEDF): drug developmental challenges ahead for a budding anti-angiogenic.
    Dass CR; Choong PF
    Pharmazie; 2008 Jan; 63(1):4-6. PubMed ID: 18271294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice.
    Jinnouchi Y; Yamagishi S; Matsui T; Takenaka K; Yoshida Y; Nakamura K; Ueda S; Imaizumi T
    Brain Res; 2007 Sep; 1167():92-100. PubMed ID: 17692294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.
    Streck CJ; Zhang Y; Zhou J; Ng C; Nathwani AC; Davidoff AM
    J Pediatr Surg; 2005 Jan; 40(1):236-43. PubMed ID: 15868591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A short peptide derived from pigment epithelial-derived factor exhibits an angioinhibitory effect.
    Ho TC; Yeh SI; Chen SL; Chu TW; Tsao YP
    BMC Ophthalmol; 2022 Feb; 22(1):88. PubMed ID: 35193548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells.
    Sheikpranbabu S; Ravinarayanan H; Elayappan B; Jongsun P; Gurunathan S
    Vascul Pharmacol; 2010; 52(1-2):84-94. PubMed ID: 20006737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A physiological approach for treating endometriosis by recombinant pigment epithelium-derived factor (PEDF).
    Chuderland D; Hasky N; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Shalgi R
    Hum Reprod; 2013 Jun; 28(6):1626-34. PubMed ID: 23466670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties.
    Yamagishi S; Matsui T; Nakamura K; Yoshida T; Shimizu K; Takegami Y; Shimizu T; Inoue H; Imaizumi T
    Microvasc Res; 2006 May; 71(3):222-6. PubMed ID: 16624340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells.
    Takenaka K; Yamagishi S; Jinnouchi Y; Nakamura K; Matsui T; Imaizumi T
    Life Sci; 2005 Nov; 77(25):3231-41. PubMed ID: 15985268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pigment epithelium-derived factor inhibits angiogenesis and growth of gastric carcinoma by down-regulation of VEGF.
    Zhang Y; Han J; Yang X; Shao C; Xu Z; Cheng R; Cai W; Ma J; Yang Z; Gao G
    Oncol Rep; 2011 Sep; 26(3):681-6. PubMed ID: 21617872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents.
    Konson A; Pradeep S; Seger R
    Cancer Res; 2010 Aug; 70(15):6247-57. PubMed ID: 20610633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization.
    Fan W; Crawford R; Xiao Y
    Differentiation; 2011 Mar; 81(3):181-91. PubMed ID: 21236558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.
    Ogata N; Wada M; Otsuji T; Jo N; Tombran-Tink J; Matsumura M
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1168-75. PubMed ID: 11923262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
    Azar DT
    Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of anti-angiogenic peptides based on pigment epithelium-derived factor can improve psoriasis.
    Abe R; Yamagishi S; Fujita Y; Hoshina D; Sasaki M; Nakamura K; Matsui T; Shimizu T; Bucala R; Shimizu H
    J Dermatol Sci; 2010 Mar; 57(3):183-91. PubMed ID: 20060688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.